Skip to content
Research Article Open access CC BY 4.0

Asymptomatic Carriage of SARS-CoV-2 in a University Population in Rosario, Argentina

Juan Pablo Scapini, María Victoria del Rosal, Juan Ignacio Isaac, Ayelen Rodriguez, Damian Ingaramo, Micaela Campora

Asian Journal of Research in Infectious Diseases · pp. 67–74 · Published 30 Oct 2023

10.9734/ajrid/2023/v14i3301

Abstract

Aims: To study the rates of SARS-CoV-2 asymptomatic carriage in a young, healthy and full vaccinated population of students in the medical area. Contribute to the knowledge of the dynamics of the endemic and its control. Study Design: Cross-sectional descriptive study. Place and Duration of Study: Faculty of Medical Sciences, Instituto Universitario Italiano de Rosario, Argentina, between August and September 2022. Methodology: 300 students were recruited. An oropharyngeal sample was taken from all the participants who completed an online electronic survey. The sampling period corresponded to weeks of low viral circulation in the province. The presence of SARS-CoV-2 was investigated by real-time RT-PCR. Results: 72.7% of the participants reported a previous infection. All the participants received at least one dose of vaccine and 56.7% completed a 3-dose schedule. Two of the 300 samples were positive for SARS-CoV-2 RNA. One was classified as presymptomatic since the individual developed compatible symptoms three days after taking the sample. The other case was the only one classified as an asymptomatic carrier, resulting in a SARS-CoV-2 portability rate of 0.33%. Conclusion: The rate obtained for asymptomatic portability in our study was surprisingly low considering that these groups shared an average of 6 hours a day in closed environments. The risk of person to person spread in this population is extremely low and does not justify the use of masks or social distancing.

COVID 19 SARS-CoV-2 Argentina asymptomatic carriage

References (25)

  1. 1 A Novel Coronavirus from Patients with Pneumonia in China, 2019 [DOI]
  2. 2 Presumed Asymptomatic Carrier Transmission of COVID-19 [DOI]
  3. 3 Coronavirus Infections—More Than Just the Common Cold [DOI]
  4. 4 Characteristics of COVID-19 Infection In Beijing [DOI]
  5. 5 Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 [DOI]
  6. 6 The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? [DOI]
  7. 7 Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis [DOI]
  8. 8 BNT162b2 mRNA COVID-19 Vaccine: First Approval [DOI]
  9. 9 Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses [DOI]
  10. 10 Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis [DOI]
  11. 11 Developing antibody tests for SARS-CoV-2 [DOI]
  12. 12 Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis [DOI]
  13. 13 A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection [DOI]
  14. 14 A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection [DOI]
  15. 15 Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis [DOI]
  16. 16 SARS-CoV-2 infections in children: Understanding diverse outcomes [DOI]
  17. 17 Age-stratified infection fatality rate of COVID-19 in the non-elderly population [DOI]
  18. 18 Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus [DOI]
  19. 19 Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis [DOI]
  20. 20 Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience [DOI]
  21. 21 Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2 [DOI]
  22. 22 Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage [DOI]
  23. 23 Does common cold coronavirus infection protect against severe SARS-CoV-2 disease? [DOI]
  24. 24 Adenovirus-vectored Ebola vaccines [DOI]
  25. 25 Bibliometric Analysis of International Scientific Production on Pharmacologic Treatments for SARS-CoV-2/COVID-19 During 2020 [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

15

Page views

0

PDF downloads

3

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.